Myeloproliferative Neoplasms (MPN) Latest Advances

Mutation profiling of chronic myeloproliferative neoplasms: improving clinical-molecular prognostic models.

Journal: Expert review of molecular diagnostics

Published: October 11, 2025

JAK2 V617F Myeloproliferative Neoplasms Support Parallel Evolution of Independent Leukemic Clones.

Journal: bioRxiv : the preprint server for biology

Published: October 03, 2025

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences.

Journal: Canadian oncology nursing journal = Revue canadienne de nursing oncologique

Published: September 02, 2025

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving.

Journal: Canadian oncology nursing journal = Revue canadienne de nursing oncologique

Published: August 28, 2025

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs).

Journal: Cancers

Published: August 20, 2025

Platelet parameters and their role in myeloproliferative neoplasms, immune-mediated thrombocytopenia, and myelodysplastic syndrome.

Journal: Laboratory medicine

Published: August 16, 2025

Prevalence of Arterial Stiffness Determined by Cardio-Ankle Vascular Index in Myeloproliferative Neoplasms.

Journal: Journal of clinical medicine

Published: August 12, 2025

Aquagenic Pruritus Questionnaire: Predicting Myeloproliferative Neoplasms in Patients with Aquagenic Pruritus.

Journal: Dermatology and therapy

Published: August 11, 2025

Comparison of depressive symptoms between patients with myeloproliferative neoplasms without the Philadelphia chromosome treated with interferon alpha and patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.

Journal: Psychiatria polska

Published: August 09, 2025

JAK2 mutational status and the contribution of TERT and JAK2 polymorphisms to the occurrence of myeloproliferative neoplasms in Eastern Morocco.

Journal: African health sciences

Published: August 08, 2025

A new era in the treatment of myeloproliferative neoplasms

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 06, 2025

Integrated one-pot RPA-CRISPR/Cas13a platform enables ultrasensitive and field-deployable JAK2 V617F detection for myeloproliferative neoplasm diagnosis.

Journal: Journal of pharmaceutical and biomedical analysis

Published: July 27, 2025

Filters

Mutation profiling of chronic myeloproliferative neoplasms: improving clinical-molecular prognostic models.

Mutation profiling of chronic myeloproliferative neoplasms: improving clinical-molecular prognostic models.

JAK2 V617F Myeloproliferative Neoplasms Support Parallel Evolution of Independent Leukemic Clones.

JAK2 V617F Myeloproliferative Neoplasms Support Parallel Evolution of Independent Leukemic Clones.

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences.

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences.

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving.

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving.

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs).

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs).

Platelet parameters and their role in myeloproliferative neoplasms, immune-mediated thrombocytopenia, and myelodysplastic syndrome.

Platelet parameters and their role in myeloproliferative neoplasms, immune-mediated thrombocytopenia, and myelodysplastic syndrome.

Prevalence of Arterial Stiffness Determined by Cardio-Ankle Vascular Index in Myeloproliferative Neoplasms.

Prevalence of Arterial Stiffness Determined by Cardio-Ankle Vascular Index in Myeloproliferative Neoplasms.

Aquagenic Pruritus Questionnaire: Predicting Myeloproliferative Neoplasms in Patients with Aquagenic Pruritus.

Aquagenic Pruritus Questionnaire: Predicting Myeloproliferative Neoplasms in Patients with Aquagenic Pruritus.

Comparison of depressive symptoms between patients with myeloproliferative neoplasms without the Philadelphia chromosome treated with interferon alpha and patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.

Comparison of depressive symptoms between patients with myeloproliferative neoplasms without the Philadelphia chromosome treated with interferon alpha and patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.

JAK2 mutational status and the contribution of TERT and JAK2 polymorphisms to the occurrence of myeloproliferative neoplasms in Eastern Morocco.

JAK2 mutational status and the contribution of TERT and JAK2 polymorphisms to the occurrence of myeloproliferative neoplasms in Eastern Morocco.

A new era in the treatment of myeloproliferative neoplasms

A new era in the treatment of myeloproliferative neoplasms

Integrated one-pot RPA-CRISPR/Cas13a platform enables ultrasensitive and field-deployable JAK2 V617F detection for myeloproliferative neoplasm diagnosis.

Integrated one-pot RPA-CRISPR/Cas13a platform enables ultrasensitive and field-deployable JAK2 V617F detection for myeloproliferative neoplasm diagnosis.